(S)-6-chloro-4-(2-cyclopropylvinyl)-4-(trifluoromethyl)-1H-benzo[d][1,3]oxazin-2(4H)-one; (E)-Dihydro Efavirenz; (4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-Benzoxazin-2-one; SR 695; USP Efavirenz Related Compound B; Efavirenz USP Related Compound B
Efavirenz Related Compound B is a fully characterized chemical compound used as a reference standard of API Efavirenz. The standard offered is compliant with regulatory guidelines. Efavirenz Related Compound B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 440124-96-9
